Addressing the Challenges of Complex Pediatric
Illness
through Innovation and Compassion.
Cancer | Heart | Neuroscience
Children's Oncology Group (COG) / Clinical Trials
PHASE 1 CLINICAL TRIALS
Through our Children’s Oncology Group (COG) membership, CHOC received a prestigious Phase 1 clinical trial designation, making us the only facility in the Southwestern United States—and one of only 21 in North America—able to offer these alternative, experimental treatments.
To learn more about current Phase 1 studies at CHOC,
click here.
Children’s Hospital of Orange County, a member of the Children’s
Oncology Group, provides patients with access to participate
in state of the art clinical research trials. A clinical trial is
a
research study that aims to determine the most effective treatment
for a particular disease. Each trial is a result of a very
detailed study of factors associated with the standard treatment
(the current
best) and variables that may lead to an improvement in survival
rates or a reduction in side effects or late effects of treatment.
Currently,
there are 59 active studies in the area of pediatric oncology
specifically designed to improve clinical outcome,
minimize potential side effects of treatments, find the
cause of certain
types of cancer, and limit the long term effects of therapy.
We
have clinical trials open for leukemia and cancers of every
organ system, either for newly diagnosed or relapsed patients.
We also collaborate with major pharmaceutical companies
to conduct clinical trials on new chemotherapeutic agents and
supportive
care to alleviate the side effects of chemotherapy.
For additional information on clinical trials available for a specific
cancer type, please visit Children's
Oncology Group at www.childrensoncologygroup.org.
For more information about The CHOC Institutes,
please
email us at institutes@choc.org
or call (800) 329-2900.
